Current Enterprise Value (EV)
Current share price (P) | $24.94 |
No. shares of common stock outstanding | 5,666,990,035 |
US$ in millions | |
Common equity (market value)1 | 141,335) |
Add: Preferred stock, no par value, at stated value (per books) | —) |
Add: Equity attributable to noncontrolling interests (per books) | 274) |
Total equity | 141,609) |
Add: Short-term borrowings, including current portion of long-term debt (per books) | 10,350) |
Add: Long-term debt, excluding current portion (per books) | 61,538) |
Total equity and debt | 213,497) |
Less: Cash and cash equivalents | 2,853) |
Less: Short-term investments | 9,837) |
Enterprise value (EV) | 200,807) |
Based on: 10-K (reporting date: 2023-12-31).
1 Common equity (market value) = Share price × No. shares of common stock outstanding
= 24.94 × 5,666,990,035
Historical Enterprise Value (EV)
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 Data adjusted for splits and stock dividends.
2 Closing price as at the filing date of Pfizer Inc. Annual Report.
3 2023 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= 27.55 × 5,646,778,425
Item | Description | The company |
---|---|---|
EV | Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments. | Pfizer Inc. EV decreased from 2021 to 2022 and from 2022 to 2023. |